FdaApplication
NDA 215413
Identifiers
- fda_app_no: NDA215413
Properties
| Property | Value |
|---|---|
| applicant_name | VIIV HEALTHCARE CO |
| application_type | NDA |
| approval_date | 2022-03-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | EQ 60MG BASE;EQ 5MG BASE;30MG | TABLET, FOR SUSPENSION;ORAL |
1 product